Year: 2026
Type: preprint
Abstract: BACKGROUND Acute liver injury (ALI) is characterized by excessive reactive oxygen species (ROS) accumulation and severe inflammation, lacking effective imaging-guided targeted therapy. PURPOSE or HYPOTHESIS: This study fabricated L-arginine-modified manganese-doped mesoporous polydopamine nanoparticles (AMM NPs) and explored their dual functions of MRI visualization and ROS-scavenging/anti-inflammatory treatment for ALI. POPULATION or SUBJECTS: AML12 hepatocytes and thioacetamide-induced ALI rat models were used. Mn-MPDA NPs (MM NPs) were prepared as the control. ASSESSMENT: The physicochemical properties, cytotoxicity, cellular uptake, and ROS elimination ability of AMM NPs were evaluated. In vivo MRI monitoring, hepatic pathological staining, ROS levels, and serum ALT, AST, TNF-α, and IL-6 were detected to assess imaging performance and therapeutic efficacy. RESULTS AMM NPs exhibited uniform spherical morphology, favorable particle size, stable zeta potential, and satisfactory L-Arg loading capacity and longitudinal relaxivity. AMM NPs showed high biosafety and time-dependent cellular uptake. The intracellular ROS level was significantly reduced by 33.64% in the AMM group (p < 0.001). In ALI models, AMM NPs prominently increased hepatic ΔT1 values for injured liver visualization. After treatment, the inflammatory area, hepatic ROS level, and serum ALT, AST, TNF-α, and IL-6 levels were markedly improved compared with the ALI group (all p < 0.05). DATA CONCLUSION: The synthesized AMM NPs possess excellent biocompatibility, accurate T1-weighted MRI imaging capability, and robust ROS scavenging and anti-inflammatory effects. This nanoparticle provides a promising imaging theranostic strategy for precise diagnosis and treatment of acute liver injury.
Source: Research Square
Institution: Affiliated Hospital of Qingdao University
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7234941944
